secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001193125-23-305948
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix receives Nasdaq deficiency notices for bid price and market value
---------------------------------------------------------------------------

- ADS closing bid below $1.00 for 30+ consecutive days, violating Minimum Bid Price Requirement.
- Market value of listed securities below $50M threshold for continued Nasdaq Global Market listing.
- Company has 180-day compliance period until June 19, 2024 to cure both deficiencies.
- Failure may lead to delisting or transfer to Nasdaq Capital Market with additional cure period.
- Company will monitor and may pursue options to regain compliance; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/0001193125-23-305948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/d736040d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-305948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer